Opinion: The new era of individualized medicine requires a ‘genetic surgery’ system
A “genetic surgery” or “interventional genetics” system for individualized treatments would be a marriage of drug development and surgical intervention.
In 2018, my daughter, Mila, became the first person in the world to receive a medicine designed for one person, an antisense oligonucleotide (ASO) called “milasen.”
Last week, the world received the breaking news that a baby named KJ had received the first personalized CRISPR treatment — one that may save his life. Just as technology is revealing thousands of genetic conditions behind previously unexplained symptoms, Mila and KJ’s stories are proving an entirely new way of treating those who suffer from genetic disease. The new era of individualized medicines is here.
.png?cb=486e63f3912bcde2d9a2136714c1a880#)
